CORRECT ANSWERS (LATEST UPDATE)
GRADED A+ 100% GUARANTEE VERIFIED BY EXPERTS
248 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NR547 CEA EXAM 2026 ACTUAL QUESTIONS AND CORRECT ANSWERS (LATEST UPDATE)
GRADED A+ 100% GUARANTEE VERIFIED BY EXPERTS. It contains 248 carefully selected questions that
reflect the most current exam content and testing strategies. Each question is accompanied by a correct answer
and a detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 248 Questions
Foundations - Application - Nr547 CEA 2026 Actual AND Correct Update A 100 Guarantee BY
Experts Advanced Nursing Nr547 Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Nr547 CEA 2026 Actual AND 1-42 Appropriate, Describes, Cost-effectiveness, Heart, Analysis
Correct Update A
100 Guarantee BY Experts
Advanced Nursing Nr547
Graduate
Acute 43-84 Finding, Appropriate, Aortic, Chronic, Presents
Finding 85-126 Appropriate, Acute, Analysis, Consistent, Cost-effectiveness
Disease 127-168 Appropriate, Medication, Prescribed, Chronic, Acute
Mechanism 169-210 Appropriate, Finding, Chronic, Failure, Requires
Chronic 211-248 Appropriate, Acute, Heart Failure, Effect, Trials
TOTAL 248 All questions include answers and detailed rationales
,Section A - Nr547 CEA 2026 Actual AND Correct 2026 /
2027 Update A 100 Guarantee BY Experts Advanced
Nursing Nr547 Graduate
Q1.
A patient with type 2 diabetes and stage 3 chronic kidney disease (eGFR 45 mL/min) is
being started on metformin. Which pharmacogenomic consideration is most critical for
this patient?
A. Metformin is contraindicated due to B. Metformin dose should be reduced by
increased risk of lactic acidosis at this 50% to prevent accumulation.
eGFR.
C. Metformin is safe at this eGFR but should D. Metformin requires renal dosing based on
be discontinued if eGFR falls below 30 genetic variants in OCT1 transporter.
mL/min.
Correct: C - Metformin is safe at this eGFR but should be discontinued if eGFR falls below
30 mL/min.
Rationale:Metformin is safe down to eGFR 30 mL/min, but it is contraindicated below that
threshold. A 50% dose reduction is not standard at eGFR 45; rather, continuation with
monitoring is appropriate. OCT1 variants affect gut absorption but not renal dosing.
Q2.
A patient with generalized anxiety disorder has failed two SSRIs. Considering the latest
evidence for treatment-resistant anxiety, which augmentation strategy is most supported
by current guidelines?
A. Adding a second SSRI to enhance B. Switching to a monoamine oxidase
receptor occupancy inhibitor (MAOI) as first-line
C. Augmenting with pregabalin or quetiapine D. Adding a benzodiazepine for long-term
control
Correct: C - Augmenting with pregabalin or quetiapine
Rationale:Pregabalin and quetiapine have evidence for augmentation in treatment-resistant
anxiety. Combining SSRIs is not recommended; MAOIs are not first-line due to safety;
benzodiazepines are not for long-term due to dependence.
Q3.
A patient presents with acute onset of unilateral vision loss, headache, and jaw
claudication. ESR is 90 mm/hr. Which diagnostic test is most definitive for confirming the
suspected diagnosis?
Page 3
, Section A - Nr547 CEA 2026 Actual AND Correct Update A 100 Guarantee BY Experts Advanced Nursing Nr547 Graduate
A. Magnetic resonance angiography (MRA) B. Temporal artery biopsy
of the cerebral vessels
C. Fluorescein angiography of the retina D. Carotid duplex ultrasound
Correct: B - Temporal artery biopsy
Rationale:Temporal artery biopsy is the gold standard for giant cell arteritis. MRA may show
vascular inflammation but is not definitive. Fluorescein angiography and carotid duplex are
not diagnostic for GCA.
Q4.
Which electrocardiographic finding is most indicative of hyperkalemia and warrants
immediate intervention?
A. Prolonged PR interval with peaked T B. ST-segment depression with U waves
waves
C. Short QT interval with prominent U D. Sinus bradycardia with low-voltage QRS
waves
Correct: A - Prolonged PR interval with peaked T waves
Rationale:Peaked T waves and prolonged PR interval are classic early signs of
hyperkalemia. U waves suggest hypokalemia; short QT with U waves is not typical;
bradycardia with low voltage is not specific.
Q5.
A patient on warfarin for atrial fibrillation presents with an INR of 5.2 and minor bleeding.
According to current guidelines, what is the most appropriate management?
A. Administer vitamin K 10 mg IV and fresh B. Hold warfarin, give vitamin K 1-2 mg
frozen plasma orally, and monitor INR
C. Administer prothrombin complex D. Give subcutaneous vitamin K 5 mg and
concentrate (PCC) immediately restart warfarin at a lower dose
Correct: B - Hold warfarin, give vitamin K 1-2 mg orally, and monitor INR
Rationale:For INR >4.5 with minor bleeding, guidelines recommend holding warfarin and
giving low-dose oral vitamin K (1-2 mg). IV vitamin K and PCC are for major bleeding;
subcutaneous is less predictable.
Q6.
Which of the following best describes the mechanism of action of SGLT2 inhibitors in
reducing cardiovascular mortality in heart failure with reduced ejection fraction?
Page 4